ECOLAB INC.
ECLAPI behind this page
ECL Q2 2025 request
Playground key active
/api/financials?ticker=ECL&year=2025&quarter=2
Pick an endpoint and run the request.Income Statement
| Metric | Q2 2025 | Q2 2024 | YoY |
|---|---|---|---|
| Revenue | 4,025.2 | 3,985.8 | +1.0% |
Show Product Lines breakouts |
|||
| Product and equipment sales | 3,156.8 | 3,173.1 | -0.5% |
| Product and equipment sales · Global Institutional and Specialty | 1,256.7 | 1,303.2 | -3.6% |
| Product and equipment sales · Global Life Sciences | 176.1 | 167.7 | +5.0% |
| Product and equipment sales · Global Water | 1,724 | 1,702.2 | +1.3% |
| Service and lease sales | 868.4 | 812.7 | +6.9% |
| Service and lease sales · Global Institutional and Specialty | 287.9 | 274.6 | +4.8% |
| Service and lease sales · Global Life Sciences | 9.8 | 8.5 | +15.3% |
| Service and lease sales · Global Pest Elimination | 317.4 | 295.7 | +7.3% |
| Service and lease sales · Global Water | 253.3 | 233.9 | +8.3% |
Show Business Segments breakouts |
|||
| Global Institutional and Specialty | 1,544.6 | 1,577.8 | -2.1% |
| Global Institutional and Specialty · Asia Pacific | 79.1 | 81 | -2.3% |
| Global Institutional and Specialty · CA | 61 | 64.2 | -5.0% |
| Global Institutional and Specialty · CN | 47.3 | 43 | +10.0% |
| Global Institutional and Specialty · Europe | 258.7 | 265.8 | -2.7% |
| Global Institutional and Specialty · India, Middle East and Africa | 23 | 25.4 | -9.4% |
| Global Institutional and Specialty · Latin America | 51 | 51.3 | -0.6% |
| Global Institutional and Specialty · Operating Segments | 1,511.7 | 1,548.1 | -2.4% |
| Global Institutional and Specialty · US | 1,024.5 | 1,047.1 | -2.2% |
| Global Life Sciences | 185.9 | 176.2 | +5.5% |
| Global Life Sciences · Asia Pacific | 11.6 | 9.1 | +27.5% |
| Global Life Sciences · CA | 0.9 | 0.8 | +12.5% |
| Global Life Sciences · CN | 13.7 | 13.9 | -1.4% |
| Global Life Sciences · Europe | 91.5 | 96.8 | -5.5% |
| Global Life Sciences · India, Middle East and Africa | 8.9 | 2.2 | +304.5% |
| Global Life Sciences · Latin America | 4.3 | 4.8 | -10.4% |
| Global Life Sciences · Operating Segments | 176.7 | 169.8 | +4.1% |
| Global Life Sciences · US | 55 | 48.6 | +13.2% |
| Global Pest Elimination | 317.4 | 295.7 | +7.3% |
| Global Pest Elimination · Asia Pacific | 8.8 | 8 | +10.0% |
| Global Pest Elimination · CA | 3.1 | 2.9 | +6.9% |
| Global Pest Elimination · CN | 15.1 | 14.9 | +1.3% |
| Global Pest Elimination · Europe | 51.2 | 46.4 | +10.3% |
| Global Pest Elimination · India, Middle East and Africa | 1.7 | 1.7 | 0.0% |
| Global Pest Elimination · Latin America | 14.6 | 15 | -2.7% |
| Global Pest Elimination · Operating Segments | 311.3 | 290.2 | +7.3% |
| Global Pest Elimination · US | 222.9 | 206.8 | +7.8% |
| Global Water | 1,977.3 | 1,936.1 | +2.1% |
| Global Water · Asia Pacific | 231.2 | 230.8 | +0.2% |
| Global Water · CA | 58.5 | 57.5 | +1.7% |
| Global Water · CN | 104 | 101.9 | +2.1% |
| Global Water · Europe | 411.2 | 395.7 | +3.9% |
| Global Water · India, Middle East and Africa | 126.4 | 122.1 | +3.5% |
| Global Water · Latin America | 194.4 | 204.8 | -5.1% |
| Global Water · Operating Segments | 1,908.5 | 1,863.2 | +2.4% |
| Global Water · US | 851.6 | 823.3 | +3.4% |
Show Consolidation Items breakouts |
|||
| Material Reconciling Items | 117 | 114.5 | +2.2% |
| Operating Segments | 3,908.2 | 3,871.3 | +1.0% |
| Cost of Revenue | 2,222.8 | 2,241 | -0.8% |
Show Product Lines breakouts |
|||
| Product and equipment sales | 1,728.4 | 1,770.6 | -2.4% |
| Service and lease sales | 494.4 | 470.4 | +5.1% |
Show Business Segments breakouts |
|||
| Corporate · Operating Segments | 2.7 | 0.7 | +285.7% |
| Global Institutional and Specialty · Operating Segments | 741.7 | 803.5 | -7.7% |
| Global Life Sciences · Operating Segments | 92.8 | 98.5 | -5.8% |
| Global Pest Elimination · Operating Segments | 176.1 | 160.3 | +9.9% |
| Global Water · Operating Segments | 1,143.5 | 1,109.8 | +3.0% |
Show Equity Components breakouts |
|||
| Accumulated Net Gain Loss From Designated Or Qualifying Cash Flow Hedges · Reclassification Out Of Accumulated Other Comprehensive Income | 2.6 | 1.2 | +116.7% |
Show Consolidation Items breakouts |
|||
| Operating Segments | 2,156.8 | 2,172.8 | -0.7% |
| Selling, General & Administrative | 1,067.7 | 1,075.7 | -0.7% |
Show Business Segments breakouts |
|||
| Corporate · Operating Segments | 48.2 | 49 | -1.6% |
| Global Institutional and Specialty · Operating Segments | 410.6 | 415.1 | -1.1% |
| Global Life Sciences · Operating Segments | 49.1 | 54.3 | -9.6% |
| Global Pest Elimination · Operating Segments | 74 | 69.9 | +5.9% |
| Global Water · Operating Segments | 458.7 | 464.8 | -1.3% |
Show Equity Components breakouts |
|||
| Accumulated Net Gain Loss From Designated Or Qualifying Cash Flow Hedges · Reclassification Out Of Accumulated Other Comprehensive Income | 0.2 | 1.3 | -84.6% |
Show Consolidation Items breakouts |
|||
| Operating Segments | 1,040.6 | 1,053.1 | -1.2% |
| Other Nonrecurring Income Expense | 24.6 | 12.2 | +101.6% |
Show Product Lines breakouts |
|||
| Product and equipment, and service and lease · Cost Of Sales | 2.5 | 0.7 | +257.1% |
Show Business Segments breakouts |
|||
| Corporate · Operating Segments | 24.1 | 12.2 | +97.5% |
Show Consolidation Items breakouts |
|||
| Operating Segments | 24.1 | 12.2 | +97.5% |
Show Income Statement Location breakouts |
|||
| Cost Of Sales | 2.5 | 0.7 | +257.1% |
| Special (gains) and charges | 24.6 | 12.2 | +101.6% |
| Operating Income | 710.1 | 656.9 | +8.1% |
Show Business Segments breakouts |
|||
| Corporate · Operating Segments | -75 | -61.9 | -21.2% |
| Global Institutional and Specialty · Operating Segments | 359.4 | 329.5 | +9.1% |
| Global Life Sciences · Operating Segments | 34.8 | 17 | +104.7% |
| Global Pest Elimination · Operating Segments | 61.2 | 60 | +2.0% |
| Global Water · Operating Segments | 306.3 | 288.6 | +6.1% |
Show Consolidation Items breakouts |
|||
| Material Reconciling Items | 23.4 | 23.7 | -1.3% |
| Operating Segments | 686.7 | 633.2 | +8.4% |
| Non-Operating Income (Expense) | -13 | -12.6 | -3.2% |
| Interest Expense Net | 63.2 | 78.8 | -19.8% |
Show Equity Components breakouts |
|||
| Accumulated Net Gain Loss From Designated Or Qualifying Cash Flow Hedges · Reclassification Out Of Accumulated Other Comprehensive Income | -0.4 | -0.4 | 0.0% |
| Income Before Taxes | 659.9 | 590.7 | +11.7% |
| Income Tax Expense (Benefit) | 131.4 | 95.7 | +37.3% |
| Net Income | 528.5 | 495 | +6.8% |
Show Equity Components breakouts |
|||
| Noncontrolling Interest | 4.3 | 4.1 | +4.9% |
| Parent | 524.2 | 490.9 | +6.8% |
| Retained Earnings | 524.2 | 490.9 | +6.8% |
| Net Income Loss Attributable To Noncontrolling Interest | 4.3 | 4.1 | +4.9% |
| Net Income | 524.2 | 490.9 | +6.8% |
| EPS (Basic) | 1.85 | 1.72 | +7.6% |
| EPS (Diluted) | 1.84 | 1.71 | +7.6% |
| Wtd Avg Shares (Basic) | 283.5 | 284.6 | -0.4% |
| Wtd Avg Shares (Diluted) | 285.4 | 287 | -0.6% |
| Interest Income | -13 | -1.4 | -828.6% |
| Comprehensive Income | 585.1 | 472.7 | +23.8% |
| Interest Expense | 76.2 | 80.2 | -5.0% |
| Operating Lease Lease Income | 137.7 | 131.6 | +4.6% |
| Professional Fees (Q) | — | — | — |
Show Disposal Group Classification breakouts |
|||
| Disposal Group Disposed Of By Sale Not Discontinued Operations · Global surgical solutions business | 0.8 | 7.3 | -89.0% |
Show Income Statement Location breakouts |
|||
| Special (gains) and charges · One Ecolab Initiative Program | 11.6 | — | — |
Balance Sheet
| Metric | Q2 2025 | Q2 2024 | YoY |
|---|---|---|---|
| Current Assets | |||
| Cash & Cash Equivalents | 1,920.9 | 384 | +400.2% |
| Accounts Receivable | 3,058.9 | 2,876.3 | +6.3% |
| Inventory | 1,569.4 | 1,505.9 | +4.2% |
| Other Assets Current | 526.6 | 420.5 | +25.2% |
| Total Current Assets | 7,075.8 | 5,752.3 | +23.0% |
| Non-Current Assets | |||
| Property, Plant & Equipment | 3,938.8 | 3,416.9 | +15.3% |
| Goodwill | 8,047.2 | 7,821.9 | +2.9% |
Show Business Segments breakouts |
|||
| Global Institutional and Specialty | 1,037.7 | 609.6 | +70.2% |
| Global Life Sciences | 2,472.7 | 2,848.9 | -13.2% |
| Global Pest Elimination | 171.4 | 159 | +7.8% |
| Global Water | 4,365.4 | — | — |
| Operating Lease Right-of-Use Assets | 762.8 | 573 | +33.1% |
| Other Non-Current Assets | 714.3 | 563.7 | +26.7% |
| Total Assets | 23,736 | 21,461.8 | +10.6% |
| Intangible Assets | 1,967.1 | 2,104 | -6.5% |
| Deferred Tax Assets | 183.8 | 121.3 | +51.5% |
| Other Assets | |||
| Intangible Assets Net Excluding Goodwill | 3,197.1 | 3,334 | -4.1% |
| Current Liabilities | |||
| Debt Current | 688.5 | 5.9 | +11569.5% |
| Accounts Payable | 1,883.5 | — | — |
| Employee Related Liabilities Current | 548.1 | 540.5 | +1.4% |
| Accrued Income Taxes Current | 198.6 | 137.2 | +44.8% |
| Other Liabilities Current | 1,589.8 | — | — |
| Total Current Liabilities | 4,908.5 | 3,847.6 | +27.6% |
| Non-Current Liabilities | |||
| Pension And Other Postretirement Defined Benefit Plans Liabilities Noncurrent | 617.1 | 627.1 | -1.6% |
| Deferred Tax Liabilities | 179.8 | 290.7 | -38.1% |
| Other Non-Current Liabilities | 557.2 | 411.1 | +35.5% |
| Total Liabilities | 14,385.4 | 13,153.9 | +9.4% |
| Other Liabilities | |||
| Long Term Debt And Capital Lease Obligations | 7,522.2 | 7,538.8 | -0.2% |
| Operating Lease Liability Noncurrent Excluded From Long Term Debt | 600.6 | 438.6 | +36.9% |
| Stockholders' Equity | |||
| Common Stock | 368.8 | 367.1 | +0.5% |
| Additional Paid In Capital Common Stock | 7,372.3 | 7,002.1 | +5.3% |
| Retained Earnings | 12,075.1 | 10,653.3 | +13.3% |
| Accumulated Other Comprehensive Income | -2,003.3 | -1,899.4 | -5.5% |
| Treasury Stock Value | -8,492.6 | -7,835.7 | -8.4% |
| Total Stockholders' Equity | 9,320.3 | 8,287.4 | +12.5% |
| Minority Interest | 30.3 | 20.5 | +47.8% |
| Stockholders Equity Including Portion Attributable To Noncontrolling Interest | 9,350.6 | 8,307.9 | +12.6% |
Show Equity Components breakouts |
|||
| Accumulated Other Comprehensive Income | -2,003.3 | -1,899.4 | -5.5% |
| Additional Paid In Capital | 7,372.3 | 7,002.1 | +5.3% |
| Common Stock | 368.8 | 367.1 | +0.5% |
| Noncontrolling Interest | 30.3 | 20.5 | +47.8% |
| Parent | 9,320.3 | 8,287.4 | +12.5% |
| Retained Earnings | 12,075.1 | 10,653.3 | +13.3% |
| Treasury Stock Common | -8,492.6 | -7,835.7 | -8.4% |
| Total Liabilities & Equity | 23,736 | 21,461.8 | +10.6% |
Cash Flow Statement
| Metric | YTD Q2 2025 | YTD Q2 2024 | YoY |
|---|---|---|---|
| Operating Activities | |||
| Depreciation | 327.9 | 316.9 | +3.5% |
| Adjustment For Amortization | 149.9 | 152.9 | -2.0% |
| Deferred Income Taxes And Tax Credits | -60.7 | -137.7 | +55.9% |
| Stock-Based Compensation | 75.9 | 82.9 | -8.4% |
| Pension And Other Postretirement Benefit Contributions | -29 | -30.8 | +5.8% |
| Pension And Other Postretirement Benefit Expense | 6.9 | 8 | -13.7% |
| Restructuring Costs | 5.4 | -9.9 | +154.5% |
| Gain Loss On Sale Of Business | 1.1 | — | — |
| Other Non-Cash Items | 6.8 | 13.6 | -50.0% |
| Change in Accounts Receivable | -122.4 | -110.1 | -11.2% |
| Change in Inventory | -76.9 | -92.3 | +16.7% |
| Increase Decrease In Other Operating Assets | 22.3 | -9.1 | +345.1% |
| Change in Accounts Payable | 7.4 | 210.1 | -96.5% |
| Increase Decrease In Other Operating Liabilities | -178.4 | -45.6 | -291.2% |
| Net Cash from Operations | 1,071.2 | 1,260.5 | -15.0% |
| Investing Activities | |||
| Capital Expenditures | -454.6 | -398.4 | -14.1% |
| Proceeds From Sale Of Productive Assets | 42.4 | 3.5 | +1111.4% |
| Payments To Acquire Businesses And Interest In Affiliates | -0.5 | -38.7 | +98.7% |
| Proceeds From Divestiture Of Businesses Net Of Cash Divested | -14.9 | — | — |
| Other Investing Activities | -20.8 | -11.8 | -76.3% |
| Net Cash from Investing | -448.4 | -445.4 | -0.7% |
| Financing Activities | |||
| Proceeds From Repayments Of Short Term Debt | -0.8 | 1.7 | -147.1% |
| Proceeds From Issuance Of Long Term Debt | 500 | — | — |
| Share Repurchases | -199.2 | -519.4 | +61.6% |
| Payments Of Dividends Common Stock | -380 | -340.7 | -11.5% |
| Proceeds From Stock Options Exercised | 139 | 154.4 | -10.0% |
| Proceeds From Payments For Other Financing Activities | -3.3 | -1.5 | -120.0% |
| Net Cash from Financing | 55.7 | -1,335.7 | +104.2% |
| Other Cash Flow | |||
| Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | -14.4 | -8.9 | -61.8% |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect Continuing Operations | 664.1 | -529.5 | +225.4% |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | 1,920.9 | 384 | +400.2% |
Values in millions USD. Source: SEC EDGAR 10-Q filing.